https://onequva.com/insights Discover expert insights, industry trends, practical guidance, and the latest ideas designed to help you make informed decisions and stay ahead. en Wed, 09 Sep 2026 08:51:11 GMT 2026-09-09T08:51:11Z en https://onequva.com/insights/503a-vs-503b <div class="hs-featured-image-wrapper"> <a href="https://onequva.com/insights/503a-vs-503b" title="" class="hs-featured-image-link"> <img src="https://onequva.com/hubfs/Quva%20Logo%20with%20Tagline%20RGB%20for%20blog%201200x857.png" alt="503A vs 503B Pharmacy: What's the Difference? | Quva Pharma" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p><span style="line-height: 20.925px;">Hospital pharmacists compounding medications for their own patients are accustomed to routine inspections from state boards of pharmacy and accrediting bodies like the Joint Commission. However, a growing number of hospital compounding operations are drawing attention from a different, more powerful regulator: the FDA. Understanding whether your pharmacy operates as a 503A facility or could benefit from a 503B outsourcing partnership, and what distinguishes the two, is the first step toward managing that risk and developing an effective sterile compounding strategy.</span><span style="line-height: 20.925px;"><br style="white-space-collapse: preserve;"></span></p> <div class="hs-featured-image-wrapper"> <a href="https://onequva.com/insights/503a-vs-503b" title="" class="hs-featured-image-link"> <img src="https://onequva.com/hubfs/Quva%20Logo%20with%20Tagline%20RGB%20for%20blog%201200x857.png" alt="503A vs 503B Pharmacy: What's the Difference? | Quva Pharma" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p><span style="line-height: 20.925px;">Hospital pharmacists compounding medications for their own patients are accustomed to routine inspections from state boards of pharmacy and accrediting bodies like the Joint Commission. However, a growing number of hospital compounding operations are drawing attention from a different, more powerful regulator: the FDA. Understanding whether your pharmacy operates as a 503A facility or could benefit from a 503B outsourcing partnership, and what distinguishes the two, is the first step toward managing that risk and developing an effective sterile compounding strategy.</span><span style="line-height: 20.925px;"><br style="white-space-collapse: preserve;"></span></p> <img src="https://track.hubspot.com/__ptq.gif?a=20300149&amp;k=14&amp;r=https%3A%2F%2Fonequva.com%2Finsights%2F503a-vs-503b&amp;bu=https%253A%252F%252Fonequva.com%252Finsights&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Wed, 09 Sep 2026 08:03:48 GMT Media.Relations@onequva.com (Quva) https://onequva.com/insights/503a-vs-503b 2026-09-09T08:03:48Z